Literature DB >> 22005755

Additive diuretic response of concurrent aminophylline and furosemide in children: a case series and a brief literature review.

Paulo Sérgio Lucas da Silva1, Vânia Euzébio de Aguiar, Marcelo Cunio Machado Fonseca.   

Abstract

Aminophylline exerts a renovascular effect, acting by adenosine receptor blockade or type IV phosphodiesterase inhibition. Clinically, these drugs have been used with furosemide to induce diuresis in adults and neonates. However, reports on use of aminophylline in diuretic-dependent children are limited to a few studies. We report a case series of four critically ill children unresponsive to furosemide continuous infusion who were subsequently given aminophylline as an adjunct diuretic in the treatment of fluid overload. No side effects were evident. Administration of aminophylline at low doses (3 mg/kg) successfully promoted increased urine output over the 6-h study period in all four children.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22005755     DOI: 10.1007/s00540-011-1250-0

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  30 in total

1.  Intermittent administration of furosemide versus continuous infusion in the postoperative management of children following open heart surgery.

Authors:  J M Klinge; J Scharf; M Hofbeck; S Gerling; S Bonakdar; H Singer
Journal:  Intensive Care Med       Date:  1997-06       Impact factor: 17.440

2.  Comparison of two fluid-management strategies in acute lung injury.

Authors:  Herbert P Wiedemann; Arthur P Wheeler; Gordon R Bernard; B Taylor Thompson; Douglas Hayden; Ben deBoisblanc; Alfred F Connors; R Duncan Hite; Andrea L Harabin
Journal:  N Engl J Med       Date:  2006-05-21       Impact factor: 91.245

3.  A randomised, double blind, placebo controlled trial of the effect of theophylline in prevention of vasomotor nephropathy in very preterm neonates with respiratory distress syndrome.

Authors:  D Cattarelli; M Spandrio; A Gasparoni; R Bottino; C Offer; G Chirico
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-10-04       Impact factor: 5.747

4.  Aminophylline as an adjunct diuretic for neonates--a case series.

Authors:  Geraldine Yin Taeng Ng; Emma Harriet Baker; Katharine Florence Mary Farrer
Journal:  Pediatr Nephrol       Date:  2004-12-04       Impact factor: 3.714

5.  Low-dose theophylline increases urine output in diuretic-dependent critically ill children.

Authors:  M Bell; E Jackson; Z Mi; J McCombs; J Carcillo
Journal:  Intensive Care Med       Date:  1998-10       Impact factor: 17.440

Review 6.  Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock.

Authors:  Joseph A Carcillo; Alan I Fields
Journal:  Crit Care Med       Date:  2002-06       Impact factor: 7.598

7.  Pulmonary edema and fluid mobilization as determinants of the duration of ECMO support.

Authors:  R E Kelly; J D Phillips; R P Foglia; H S Bjerke; L T Barcliff; L Petrus; T R Hall
Journal:  J Pediatr Surg       Date:  1991-09       Impact factor: 2.545

8.  The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance.

Authors:  Michael M Givertz; Barry M Massie; Tara K Fields; Leeanne L Pearson; Howard C Dittrich
Journal:  J Am Coll Cardiol       Date:  2007-10-01       Impact factor: 24.094

9.  Effects of theophylline on renal insufficiency in neonates with respiratory distress syndrome.

Authors:  F Huet; D Semama; M Grimaldi; J P Guignard; J B Gouyon
Journal:  Intensive Care Med       Date:  1995-06       Impact factor: 17.440

Review 10.  Fluid management in patients with acute respiratory distress syndrome.

Authors:  Andrew L Rosenberg
Journal:  Respir Care Clin N Am       Date:  2003-12
View more
  1 in total

1.  No Requirement for Targeted Theophylline Levels for Diuretic Effect of Aminophylline in Critically Ill Children.

Authors:  Katie Park; Lindsay C Trout; Cong Xu; Ming Wang; Robert F Tamburro; E Scott Halstead
Journal:  Pediatr Crit Care Med       Date:  2018-08       Impact factor: 3.624

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.